Junior Ibuprofen Suspension

国: マルタ

言語: 英語

ソース: Malta Medicines Authority

即購入

ダウンロード 製品の特徴 (SPC)
14-06-2024

有効成分:

IBUPROFEN

から入手可能:

Galpharm Healthcare Limited Wrafton, Braunton, North Devon, EX33 2DL, United Kingdom

ATCコード:

M01AE01

INN(国際名):

IBUPROFEN 100 mg/5ml

医薬品形態:

ORAL SUSPENSION

構図:

IBUPROFEN 100 mg/5ml

処方タイプ:

OTC

治療領域:

ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS

認証ステータス:

Withdrawn

承認日:

2006-12-20

製品の特徴

                                Page 1 of 5
 
 
SUMMARY OF PRODUCT CHARACTERISTICS 
 
 
 
1.  TRADE NAME OF THE MEDICINAL PRODUCT 
 
Junior Ibuprofen Suspension 
 
 
2.  QUALITATIVE AND QUANTITATIVE COMPOSITION 
 
Active Ingredient: 
Ibuprofen BP 100 mg / 5ml                            
 
Excipients: 
Dispersible Cellulose (Avicel RC591),
Sodium Methylparaben, Sodium Propylparaben, Citric Acid 
Anhydrous, Saccharin Sodium, Sodium Benzoate, Juicy
Orange Flavour, Hydrogenated Glucose Syrup, 
Xanthan Gum, Polysorbate 80, Purified Water. 
 
 
3. PHARMACEUTICAL 
FORM 
 
Suspension for oral administration 
 
 
4. CLINICAL 
PARTICULARS 
 
 
4.1 THERAPEUTIC INDICATIONS 
 
For reduction of fever (including post immunisation fever;) and
relief of mild to moderate pain such as 
headache, sore throat, earache, teething pain and toothache, cold
and flu symptoms, minor aches and 
sprains. 
 
4.2 POSOLOGY AND METHOD OF ADMINISTRATION 
 
Children 8 to 12 years: 10 ml three to four times daily. 
Children 3 to 7 years:  5 ml three to four times daily. 
Children 1 to 2 years:  2.5 ml three to four times daily. 
Infants 6 months to 1 year:  2.5 ml three times daily. 
 
Not recommended for children under 6 months of age. 
 
For post immunisation fever: 2.5ml followed by one further 2.5ml 6
hours later, if necessary. No more 
than 2 doses in 24 hours. If fever is not reduced, consult your
doctor. 
 
4.3 CONTRAINDICATIONS 
 
Patients with a known hypersensitivity to Ibuprofen, Aspirin or any
of the products constituents. 
 
Patients with a history of bronchospasm, rhinitis
or urticaria particularly associated with therapy with 
aspirin or other anti-inflammatory drugs. 
 
Page 2 of 5
 
 
Patients with active peptic ulceration or a history of peptic
ulceration. 
 
Children under 6 months.  
 
 
 
 
 
 
 
4.4 SPECIAL WARNING AND PRECAUTIONS FOR USE 
 
Should be used with care in patients with renal, hepa
                                
                                完全なドキュメントを読む
                                
                            

この製品に関連するアラートを検索

ドキュメントの履歴を表示する